scholarly journals The Experimental Analysis of Human Behavior: History, Current Status, and Future Directions

1987 ◽  
Vol 37 (1) ◽  
pp. 3-3 ◽  
Author(s):  
William Buskist ◽  
Samuel M. Dietz ◽  
Barbara Etzel ◽  
Mark Galizio ◽  
Aaron Brownstein ◽  
...  
2016 ◽  
Vol 17 (8) ◽  
pp. 755-762 ◽  
Author(s):  
Xu Zhou ◽  
Renhe Liu ◽  
Shuo Qin ◽  
Ruilian Yu ◽  
Yao Fu

Author(s):  
Christopher Cambron ◽  
Richard F. Catalano ◽  
J. David Hawkins

This chapter presents an overview of the social development model (SDM)—a general theory of human behavior that integrates research on risk and protective factors into a coherent model. The goal of this synthesis is to provide more explanatory power than its component theories. This chapter first specifies the model constructs and their hypothesized relationships to prosocial and antisocial behaviors. It then provides a synthesis of what has been learned from empirical tests of social development hypotheses for predicting pro- and antisocial behaviors. This chapter also highlights interventions derived from the SDM and summarizes their impact on pro- and antisocial behaviors. Finally, the chapter concludes by presenting future directions for SDM-based research.


2020 ◽  
Vol 11 ◽  
Author(s):  
Nathaniel Edward Bennett Saidu ◽  
Chiara Bonini ◽  
Anne Dickinson ◽  
Magdalena Grce ◽  
Marit Inngjerdingen ◽  
...  

2021 ◽  
Author(s):  
Haoru Dong ◽  
Xinhua Shu ◽  
Qiang Xu ◽  
Chen Zhu ◽  
Andreas M. Kaufmann ◽  
...  

AbstractHuman papillomavirus (HPV) infection identified as a definitive human carcinogen is increasingly being recognized for its role in carcinogenesis of human cancers. Up to 38%–80% of head and neck squamous cell carcinoma (HNSCC) in oropharyngeal location (OPSCC) and nearly all cervical cancers contain the HPV genome which is implicated in causing cancer through its oncoproteins E6 and E7. Given by the biologically distinct HPV-related OPSCC and a more favorable prognosis compared to HPV-negative tumors, clinical trials on de-escalation treatment strategies for these patients have been studied. It is therefore raised the questions for the patient stratification if treatment de-escalation is feasible. Moreover, understanding the crosstalk of HPV-mediated malignancy and immunity with clinical insights from the proportional response rate to immune checkpoint blockade treatments in patients with HNSCC is of importance to substantially improve the treatment efficacy. This review discusses the biology of HPV-related HNSCC as well as successful clinically findings with promising candidates in the pipeline for future directions. With the advent of various sequencing technologies, further biomolecules associated with HPV-related HNSCC progression are currently being identified to be used as potential biomarkers or targets for clinical decisions throughout the continuum of cancer care.


Author(s):  
Minh Tu Nguyen ◽  
Zita Sebesvari ◽  
Maxime Souvignet ◽  
Felix Bachofer ◽  
Andreas Braun ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document